Michael Grissinger - May 16, 2022 Form 3 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Director
Signature
/s/ Scott M. Coiante, attorney-in-fact
Stock symbol
APRE
Transactions as of
May 16, 2022
Transactions value $
$0
Form type
3
Date filed
5/26/2022, 04:15 PM
Next filing
Aug 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding APRE Stock Option (right to buy) May 16, 2022 Common Stock 72.6K $0.44 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit 24 - Power of Attorney